Skip to main content
TipRanks
Go Ultimate75% OFF

iShares U.S. Pharmaceuticals ETF (IHE) Price & Chart

IHE ETF Chart & Stats

$109.64
At close: 4:00 PM EST
$100$105$110Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$109.43 - $112.29
52-Week Range
$80.25 - $112.29
Previous Close
$111.03
Volume
155.16K
Average Volume (3M)
243.97K
AUM
1.74B
NAV
109.59
Expense Ratio
0.37%
Holdings Count
54
Beta
0.41
Inception Date
May 01, 2006
Shares Outstanding
15,650,000
Standard Deviation
N/A

ETF Overview

iShares U.S. Pharmaceuticals ETF

The iShares U.S. Pharmaceuticals ETF (IHE) is a specialized investment vehicle designed for those looking to gain exposure to the rapidly evolving pharmaceuticals sector within the broader health care industry. As a sector-focused ETF, IHE provides investors with targeted access to a niche market that plays a pivotal role in global health and innovation. By investing in a diversified portfolio of U.S.-based pharmaceutical companies, this ETF offers an opportunity to capitalize on the growth potential and resilience of firms involved in the development, production, and marketing of drugs and treatments that address a wide range of medical conditions. IHE is particularly appealing to investors seeking to tap into the cutting-edge advancements and robust demand for pharmaceutical products, driven by an aging global population and ongoing medical breakthroughs. This fund provides a unique blend of stability and growth potential, as pharmaceuticals are often seen as a defensive sector with the ability to perform well across various economic cycles. With iShares U.S. Pharmaceuticals ETF, investors can seamlessly access a curated selection of industry leaders, from established giants to emerging innovators, thus positioning their portfolios to benefit from the dynamic landscape of health care solutions.

IHE ETF News

IHE ETF FAQ

What was IHE’s price range in the past 12 months?
IHE’s lowest price in the past 12 months was $80.25 and its highest was $112.29.
What is the AUM of IHE?
As of Nov 16, 2026, the AUM of IHE is $1.74B.
Is IHE overvalued?
Based on Wall Street analyst price targets for IHE’s holdings, IHE’s price is currently undervalued.
Does IHE pay dividends?
Yes. IHE pays dividends quarterly. Its most recent dividend was $0.28 per share, and its annual dividend yield is 1.31%. See more information on IHE dividends here.
How many shares outstanding does IHE have?
IHE has 15,650,000 shares outstanding.
Which hedge fund is a major shareholder of IHE?
Fisher Asset Management LLC is among the largest hedge fund holders of IHE, with a position valued at $271.8M.